Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults

Temporal lobe epilepsy (TLE) is the most common type of focal epilepsy in adults. Experimental and clinical data indicate that neuroinflammation and neurodegeneration accompanying epileptogenesis make a significant contribution to the chronicity of epilepsy and the development of drug resistance in...

Full description

Bibliographic Details
Main Authors: Yulia S. Panina, Elena E. Timechko, Anna A. Usoltseva, Kristina D. Yakovleva, Elena A. Kantimirova, Diana V. Dmitrenko
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/1/83
_version_ 1797438811912798208
author Yulia S. Panina
Elena E. Timechko
Anna A. Usoltseva
Kristina D. Yakovleva
Elena A. Kantimirova
Diana V. Dmitrenko
author_facet Yulia S. Panina
Elena E. Timechko
Anna A. Usoltseva
Kristina D. Yakovleva
Elena A. Kantimirova
Diana V. Dmitrenko
author_sort Yulia S. Panina
collection DOAJ
description Temporal lobe epilepsy (TLE) is the most common type of focal epilepsy in adults. Experimental and clinical data indicate that neuroinflammation and neurodegeneration accompanying epileptogenesis make a significant contribution to the chronicity of epilepsy and the development of drug resistance in TLE cases. Changes in plasma and serum concentrations of proteins associated with neuroinflammation and neurodegeneration can be predictive biomarkers of the course of the disease. This study used an enzyme-linked immunosorbent assay of the following plasma proteins: brain-derived neurotrophic factor (<i>BDNF</i>), tumor necrosis factor alpha (<i>TNFa</i>), and high-mobility group protein B1 (<i>HMGB1</i>) in patients with mesial TLE to search for biomarkers of the disease. The objective of the study was to examine biomarkers of the neuroinflammation and neurodegeneration of plasma: <i>BDNF</i>, <i>TNFa</i>, and <i>HMGB1</i>. The aim of the study was to identify changes in the concentration of circulating pro-inflammatory and neurotrophic factors that are prognostically significant for the development of drug resistance and the course of TLE. A decrease in the concentration of <i>BDNF</i>, <i>TNFa</i>, and <i>HMGB1</i> was registered in the group of patients with TLE compared with the control group. A significant decrease in the concentration of HMGB1 in patients with drug-resistant TLE was observed. Aberrations in plasma concentrations of <i>BDNF</i>, <i>TNFa</i>, and <i>HMGB1</i> in patients with TLE compared with the controls have been confirmed by earlier studies. A decrease in the expression of the three biomarkers may be the result of neurodegenerative processes caused by the long course of the disease. The results of the study may indicate the acceptability of using <i>HMGB1</i> and <i>TNFa</i> as prognostic biological markers to indicate the severity of the disease course and the risk of developing drug resistance.
first_indexed 2024-03-09T11:42:41Z
format Article
id doaj.art-955064b050fa4d17a8ba1c9769a32c6a
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-09T11:42:41Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-955064b050fa4d17a8ba1c9769a32c6a2023-11-30T23:28:46ZengMDPI AGMetabolites2218-19892023-01-011318310.3390/metabo13010083Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in AdultsYulia S. Panina0Elena E. Timechko1Anna A. Usoltseva2Kristina D. Yakovleva3Elena A. Kantimirova4Diana V. Dmitrenko5Department of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, RussiaDepartment of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, RussiaDepartment of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, RussiaDepartment of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, RussiaDepartment of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, RussiaDepartment of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, RussiaTemporal lobe epilepsy (TLE) is the most common type of focal epilepsy in adults. Experimental and clinical data indicate that neuroinflammation and neurodegeneration accompanying epileptogenesis make a significant contribution to the chronicity of epilepsy and the development of drug resistance in TLE cases. Changes in plasma and serum concentrations of proteins associated with neuroinflammation and neurodegeneration can be predictive biomarkers of the course of the disease. This study used an enzyme-linked immunosorbent assay of the following plasma proteins: brain-derived neurotrophic factor (<i>BDNF</i>), tumor necrosis factor alpha (<i>TNFa</i>), and high-mobility group protein B1 (<i>HMGB1</i>) in patients with mesial TLE to search for biomarkers of the disease. The objective of the study was to examine biomarkers of the neuroinflammation and neurodegeneration of plasma: <i>BDNF</i>, <i>TNFa</i>, and <i>HMGB1</i>. The aim of the study was to identify changes in the concentration of circulating pro-inflammatory and neurotrophic factors that are prognostically significant for the development of drug resistance and the course of TLE. A decrease in the concentration of <i>BDNF</i>, <i>TNFa</i>, and <i>HMGB1</i> was registered in the group of patients with TLE compared with the control group. A significant decrease in the concentration of HMGB1 in patients with drug-resistant TLE was observed. Aberrations in plasma concentrations of <i>BDNF</i>, <i>TNFa</i>, and <i>HMGB1</i> in patients with TLE compared with the controls have been confirmed by earlier studies. A decrease in the expression of the three biomarkers may be the result of neurodegenerative processes caused by the long course of the disease. The results of the study may indicate the acceptability of using <i>HMGB1</i> and <i>TNFa</i> as prognostic biological markers to indicate the severity of the disease course and the risk of developing drug resistance.https://www.mdpi.com/2218-1989/13/1/83temporal lobe epilepsybiomarkersdrug resistanceneuroinflammationneurodegeneration
spellingShingle Yulia S. Panina
Elena E. Timechko
Anna A. Usoltseva
Kristina D. Yakovleva
Elena A. Kantimirova
Diana V. Dmitrenko
Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults
Metabolites
temporal lobe epilepsy
biomarkers
drug resistance
neuroinflammation
neurodegeneration
title Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults
title_full Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults
title_fullStr Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults
title_full_unstemmed Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults
title_short Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults
title_sort biomarkers of drug resistance in temporal lobe epilepsy in adults
topic temporal lobe epilepsy
biomarkers
drug resistance
neuroinflammation
neurodegeneration
url https://www.mdpi.com/2218-1989/13/1/83
work_keys_str_mv AT yuliaspanina biomarkersofdrugresistanceintemporallobeepilepsyinadults
AT elenaetimechko biomarkersofdrugresistanceintemporallobeepilepsyinadults
AT annaausoltseva biomarkersofdrugresistanceintemporallobeepilepsyinadults
AT kristinadyakovleva biomarkersofdrugresistanceintemporallobeepilepsyinadults
AT elenaakantimirova biomarkersofdrugresistanceintemporallobeepilepsyinadults
AT dianavdmitrenko biomarkersofdrugresistanceintemporallobeepilepsyinadults